-
$4,700 Read More Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT[...]
Global antidiabetics market is expected to reach USD 84.13 billion by 2020. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by tri... -
$4,700 Read More Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market Analysis By Product (Corticosteroids, Intravenous Immunoglobulin, Anti-D [...]
Global ITP therapeutics market is expected to reach USD 566.37 million by 2020. Introduction of new drugs especially pertaining to TPO-RA and IVIG classes is expected to serve this market as a high impact rendering driver. Presence of favorable government regulations such as the Orphan Drug Act i... -
$4,700 Read More Autoimmune Disease Diagnostics Market Analysis By Product (Systemic, Localized, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ank[...]
Global autoimmune disease diagnostics market is expected to reach USD 14.17 billion by 2020. Growing prevalence of autoimmune diseases coupled with the presence of favorable government initiatives such as the Affordable Care Act is expected to positively reinforce the autoimmune disease diagnosti...
Sorry, there is no ad related to this category!
-
$1,500 Read More Clevexel Pharma SAS – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Clevexel Pharma SAS – Product Pipeline Review – 2015’, provides an overview […]
-
$2,500 Read More Helminthiasis Global Clinical Trials Review, H1, 2016
GlobalData’s clinical trial report, “Helminthiasis Global Clinical Trials Review, H1, 2016″ provides an overview of […]
-
$2,000 Read More Hyperalgesia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Hyperalgesia – Pipeline Review, H1 2016’, provides an overview of the Hyperalgesia […]
-
$2,000 Read More Acute Respiratory Distress Syndrome – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome, […]
-
$4,995 Read More Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 –...
Type 2 Diabetes Mellitus (T2DM) is a metabolic disease characterized by chronic hyperglycemia (high blood […]
-
$1,995 Read More Country Focus: Healthcare, Regulatory and Reimbursement Landscape – India
GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement […]
-
$2,500 Read More Genital Herpes Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Genital Herpes. Report […]
-
$2,000 Read More Functional (Non Ulcer) Dyspepsia – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Functional (Non Ulcer) Dyspepsia – Pipeline Review, H1 2016’, provides an overview […]
-
$2,000 Read More Atrial Fibrillation – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Atrial Fibrillation – Pipeline Review, H1 2016’, provides an overview of the […]
-
$6,995 Read More Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) – Identifyin...
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the […]